CDH1 and cancer: Those authors showed that although downregulation of E-cadherin has previously been associated with the development of neoplasia and cancer, it seems to have little to do with the carcinogenic process and seems to be unrelated to the ability of the E6 and E7 proteins to bind and degrade pRb or p53 [40].